Genomic and transcriptional profiling stratifies VQ myeloma lines into two clusters with distinct risk signatures and drug responses
E. Flietner, M. Yu, A. Rajagopalan, Y. Zhou, Y. Feng, A. Veltri, T. Lasho, Z. Wen, Y. Sun, M. M. Patnaik, N. S. Callander, F. Asimakopoulos, D. Wang, J. Zhang
bioRxiv · Aug 21, 2022 · PreprintCancer Biology